IM

Isaac Manke

Partner at Acorn Bioventures

United States

Investor
VC

Invests in

Sectors:

BioTech

Locations:

United States

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Business Strategy
Capital Markets
Competitive Analysis
Corporate Development
Due Diligence
Entrepreneurship
Equities
Equity Research
Financial Modeling
Healthcare
IPO
Investment Banking
Investments
Investor Relations
Lifesciences
Management Consulting
Market Analysis
Medical Devices
Mergers

Education

Lists including Isaac

AT
AS
AT
AH

All Series A Investors

14752 people

Investments

Q32 Bio

Series B

Total Funding: $150M

OnKure Therapeutics

Series B

Total Funding: $110M

ONK Therapeutics

Series A

Total Funding: $22M

True North Therapeutics

Series C

Total Funding: $40M

Work Experience

AB
Acorn Bioventures

2020

  • Partner

    2020

NL
New Leaf Venture Partners

2009 - 2019

  • General Partner

    2009 - 2019

A
AllianceBernstein

2007 - 2009

  • Biotechnology Research Associate

    2007 - 2009

DB
Deutsche Bank

2006 - 2007

  • Associate Analyst - Biotechnology Equity Research

    2006 - 2007

HA
Health Advances

2005 - 2006

  • Senior Analyst

    2005 - 2006

    Health Advances is a strategy consulting firm that specializes in the biotechnology, medical device and pharmaceutical industries.